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Several genetic lesions are associated with the genesis of
human colorectal carcinomas including mutational activation
of Ki-ras and p53, and loss of heterozygosity involving
presumptive oncosuppressor loci on 5q21, 17pl3, and 18q22
(Fearon & Vogelstein, 1990). Abnormalities at the 17p13
locus are recorded in many types of tumours (Nigro et al.,
1989) but there is no evidence at present that the 5q and 18q
loci are involved in sporadic neoplasia other than that of
colorectal mucosa. Although the 17p13 locus is-b-probably
congenic with p53, and the product of the 18q22 gene
appears to be a cell adhesion molecule, the function for all of
these genes in oncosuppression is poorly understood. The
ideal vehicle for assay and analysis of these unknown gene
functions would be a colorectal cancer cell line in which the
oncosuppressor genes were known to be aberrant or inactive.
In theory, replacement of even one copy of the appropriate
intact oncosuppressor gene might then restore phenotype to
normality. Recent studies have demonstrated oncosuppres-
sion of this type on introduction of normal DNA from the
retinoblastoma and Wilms' susceptibility loci, into tumour
cell lines (Huang et al., 1988; Weissman et al., 1987). How-
ever, for none of the long-established colorectal cancer lines
readily available is status at critical oncosuppressor loci
known. Moreover long-established lines commonly acquire
additional genetic rearrangements during culture (Brattain et
al., 1983; Park et al., 1987), which may not be reversible by
correction of the original oncosuppressor defect alone. We
therefore set out to develop a series of lines from primary
colorectal tumours, defined both in terms of status at onco-
suppressor loci on chromosomes 5, 17 and 18, and the
stability of each locus on serial passage.
Portions of carcinoma obtained from surgical resection
specimens were xenografted as described by Lewko et al.
(1989), into pairs of immunosuppressed (thymectomised, ir-
radiated and arabinoside-C treated) CBA mice (Steel et al.,
1978), with the modification that portions no greater than
5 mm3 were implanted dorsally at initial xenograft and at
subsequent transplantations.
From a consecutive series of 28 cancers implanted, 11 grew
to passage and eight were xenografted for more than five
passages, one of which has now reached passage 16. At each
serial passage excess tumour tissue was divided for analysis
allowing the characterisation of xenografted tumours at var-
ious passage intervals, and the comparison of these with the
primary tumour (portions of which were always stored both
frozen and fixed at original resection). Haematoxylin and
eosin stained paraffin sections of both primary tumour and
xenografts fixed in 10% buffered formalin at all passages,
showed that the original histological pattern for each primary
tumour was conserved throughout serial passage. Although
most of the lines fell into the class of adenocarcinomas of
average degree of differentiation, extremes of both good and
very poor differentiation were represented (Figure 1). No
metastases were observed in mice.
To study the status of alleles closely linked to each of three
putative colon-associated oncosuppressor loci, genomic DNA
was prepared from frozen xenografted tumours at various
passages, and compared with DNA from primary tumour
tissue and normal colorectal mucosa or peripheral blood
leukocytes from the donor patient. Methods for DNA pre-
paration, Southern blotting and probes and conditions for
hybridisation have been previously published (Ashton-
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Figure 1 Histological comparisons of original colorectal tumours with the corresponding xenografts. a, A poorly differentiated
adenocarcinoma AGDU. b, Corresponding xenograft at 5th passage XAGDU4. c, A well differentiated adenocarcinoma MUCO.
d, Corresponding xenograft at 11th passage XMUCO10. e, A moderately differentiated adenocarcinoma CHKE. f, Corresponding
xenograft at 6th passage XCHKE5.
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Rickardt et al., 1989). Probes used were: for chromosome 5q:
pYN5.48 (Nakamura et al., 1988a), pEF5.44 (Dunlop et al.,
1990) n227 (Meera Khan et al., 1988; Dunlop et al., 1989),
and two new probes pL5.62 and pL5.713 which map between
nc227 and YN5.48 (Y. Nakamura, personal communication);
for 17p: pYNZ22 (Nakamura et al., 1988b), pMCT35.1
(Carlson et al., 1988); and for 18q: pBV15.65 (Vogelstein et
al., 1988). Almost all of these probes detect highly polymor-
phic sequences. pBV15.65 is situated within the 18q oncosup-
pressor gene, pMCT35.1 lies close to the p53 gene and the 5q
probes are distributed through the APC locus over no more
than 15mb.
Table I summarises allelic losses or retentions found for
the parental normal and tumour DNA pairs at each locus. In
all cases studied, the allelic status of xenograft DNA was
unchanged from that of its primary tumour. For eight
tumours this genetic stability was demonstrated over at least
four xenograft passages (approximately 4 months) and in two
(one of which showed allelic retention at5q and 17p) over
11
passages (approximately 11 months). A variety of combina-
tions of allelic losses and retentions are represented, broadly
similar to those observed by ourselves and others in large
unselected series of primary tumours (Ashton-Rickardt et al.,
1989; Vogelstein et al., 1988). It appears from these observa-
tions that the selection pressures which encourage growth of
human colorectal cancer xenografts in immunosuppressed
animals do not include allelic losses around the oncosuppres-
sor loci commonly affected in human carcinogenesis in situ.
Although our primary aim was to establish the stability of
the lines at critical oncosuppressor loci, DNA ploidy was
measured by flow cytometry as a global, if crude, index of
total nuclear DNA content. Frozen tissues from both passage
5 xenografts and primary tumour were dissociated and stained
with 0.62M propidium iodide as described by Vindelov (1983),
and analysed at an excitation wavelength of 488 nm in a
Coulter Epics CS flow cytometer. On the basis of an internal
chicken red blood cell standard, the presence of a human
diploid peak could be confirmed in every case. This was given
a ploidy value of 1, and any additional peaks were then
assumed to be aneuploid, and their DNA index (DI) derived
from their position relative to the diploid peak. In all cases,
xenograft DI was similar to that of the relevant primary
tumour (example shown in Figure 2), including four tumours
remaining diploid after five or nine serial passages in mice, and
one after 14 passages(15 months). A similarly high degree of
conservation of genetic stability throughout xenograft passage
in immunodeficient mice has been confirmed both karyotyp-
ically and at the genetic level by Lefrancois et al. (1989).
The demonstrated lack of genetic change for defined onco-
suppressor loci qualifies these xenografts as favourable tu-
mour models for analysis of oncosuppressor function, by
re-introduction of the normal genes. Since growth in vitro is a
prerequisite for genetic manipulation, tumour tissues re-
moved immediately on to ice from animals at or following
Table I Allelic status at three oncosuppressor loci, and DNA
a set of 11 xenografts
Line Sq 17p 18q DNA Index
GRBO R (5) R (4) R (2) 1.0 (5)
MUCO R(10) R(10) 1.0(14)
RHSP L(10) L(10) 1.7-1.9(12)
CHKE R (4) R (4) R(3) 1.1-1.2 (9)
DABU* R (5) R (5) NI 1.0 (5)
ARNE* R (4) L (5) L (5) 1.5-1.6 (5) MASM* R (5) R (5) R (2) 1.0 (9)
JOMcL* R (4) R (4) NI 1.0 (5)
JACA L (2) L (2) L (2) 1.6
CARO L (1) L (1) L(1) 1.4
JOWR R (1) R (1) R(1) 1.0
(= highest xenograft passage no. analysed; - = not done;
NI
= non-informative (patient homozygous for alleles studied);
R = allele retained; L = allele lost; * = line xenografted over more than
five passages. In all cases the allelic status of the xenografts throughout
passage was identical with that of the primary tumour.
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Figure 2 Flow cytometric comparison of an aneuploid primary
tumour (DNA index 1.7); arrowed, with the xenograft at passage
5 (DNA index 1.9). Diploid peak position is marked *.
Figure 3 Phase contrast microscopy of XRHSP xenograft tu-
mour epithelial cells growing in culture as islands (I) surrounded
by feeder cells.
passage 5 were processed and seeded as primary cultures on
collagen coated flasks with mouse feeder cells, as described
by Paraskeva (1984). Epithelial cells from every xenograft
line grew in vitro as flat islands of cells spreading radially
across the collagen surface towards neighbouring islands
(Figure 3). Two slightly faster growing lines were observed
over three passages in vitro, and a third has now grown
rapidly over 100 days, requiring a weekly split ratio of up to
1:20. On subcutaneous re-injection into immunosuppressed
mice, these cells continued to show the same allelic status and
morphology as the primary tumour.
In conclusion, the xenograft lines described above repre-
sent a variety of defined and stable combinations of oncosup-
pressor gene status and will therefore provide a useful re-
source for the study of the functions of the genes involved in
human colorectal cancer, and their interactions with each
other.
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